542 related articles for article (PubMed ID: 32169057)
1. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
[TBL] [Abstract][Full Text] [Related]
2. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
Sasaki T; Nakamura K; Naito S
Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
[TBL] [Abstract][Full Text] [Related]
5. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
Sairaku A; Yoshida Y; Nakano Y; Kihara Y
Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
[TBL] [Abstract][Full Text] [Related]
6. Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
De Maria E; Cappelli S; Cappato R
Heart Rhythm; 2013 Dec; 10(12):1807-9. PubMed ID: 23933298
[No Abstract] [Full Text] [Related]
7. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725
[TBL] [Abstract][Full Text] [Related]
8. Successful defibrillation verification in subcutaneous implantable cardioverter-defibrillator recipients by low-energy shocks.
Biffi M; Ziacchi M; Angeletti A; Castelli A; Massaro G; Martignani C; Lovecchio M; Valsecchi S; Diemberger I
Clin Cardiol; 2019 Jun; 42(6):612-617. PubMed ID: 30989668
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of catheter ablation in high-risk patients with Brugada syndrome refusing an implantable cardioverter defibrillator implantation.
Li L; Ding L; Zhou L; Wu L; Zheng L; Zhang Z; Xiong Y; Zhang Z; Yao Y
Europace; 2023 Dec; 26(1):. PubMed ID: 37889958
[TBL] [Abstract][Full Text] [Related]
10. High-risk Brugada syndrome: factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation.
Santinelli V; Ciconte G; Manguso F; Anastasia L; Micaglio E; Calovic Z; Vicedomini G; Mazza B; Vecchi M; Mecarocci V; Locati ET; Boccellino A; Negro G; Napolano A; Giannelli L; Pappone C
Europace; 2023 Dec; 26(1):. PubMed ID: 38252933
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death - Primary Japanese Experience.
Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter-Defibrillator Systems-A Simple Issue?
Frommeyer G; Zumhagen S; Dechering DG; Larbig R; Bettin M; Löher A; Köbe J; Reinke F; Eckardt L
J Am Heart Assoc; 2016 Mar; 5(3):e003181. PubMed ID: 27068637
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
Nademanee K; Chung FP; Sacher F; Nogami A; Nakagawa H; Jiang C; Hocini M; Behr E; Veerakul G; Jan Smit J; Wilde AAM; Chen SA; Yamashiro K; Sakamoto Y; Morishima I; Das MK; Khongphatthanayothin A; Vardhanabhuti S; Haissaguerre M
Circulation; 2023 May; 147(21):1568-1578. PubMed ID: 36960730
[TBL] [Abstract][Full Text] [Related]
14. Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
Gonzalez Corcia MC; Sieira J; Pappaert G; de Asmundis C; Chierchia GB; La Meir M; Sarkozy A; Brugada P
J Am Coll Cardiol; 2018 Jan; 71(2):148-157. PubMed ID: 29325638
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated Reactivity of Parasympathetic Nerves Is Involved in Ventricular Fibrillation in J-Wave Syndrome.
Shinohara T; Kondo H; Otsubo T; Fukui A; Yufu K; Nakagawa M; Takahashi N
J Cardiovasc Electrophysiol; 2017 Mar; 28(3):321-326. PubMed ID: 27885745
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
Russo V; Caturano A; Guerra F; Migliore F; Mascia G; Rossi A; Nesti M; Santobuono VE; Attena E; Tola G; Sciarra L; Conte G; Paoletti Perini A; Francia P; Dendramis G; Palamà Z; Albani S; Ottonelli Ghidini A; Calò L; D'Onofrio A; Baldi E;
Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560
[TBL] [Abstract][Full Text] [Related]
18. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of Defibrillation Threshold Testing in Patients With Hypertrophic Cardiomyopathy.
Francia P; Adduci C; Semprini L; Palano F; Santini D; Musumeci B; Santolamazza C; Volpe M; Autore C
J Cardiovasc Electrophysiol; 2017 Jan; 28(1):103-108. PubMed ID: 27862589
[TBL] [Abstract][Full Text] [Related]
20. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.
Moubarak JB; Karasik PE; Fletcher RD; Franz MR
J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
